Neufeld Leah R's Form 4 filing
Immuneering Corp (IMRX) · filed Jul 7, 2025
- Accession no.
- 0001790340-25-000096
- Filed
- Jul 7, 2025
- Trade date
- Jul 2, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $2.50K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Neufeld Leah RCIK 0001950673 | Officer (CHIEF PEOPLE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | Class A Common Stock | PPurchaseAcquired | +700 | $3.57 | +$2,499 | 10,729 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.